What are the ten WHO-defined complications of severe malaria and their definitions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

WHO Complications of Severe Malaria

The WHO defines severe malaria by the presence of any one of ten major complications, which represent life-threatening organ dysfunction requiring immediate intervention. These criteria apply primarily to P. falciparum but have been adapted for P. vivax and P. knowlesi 1.

The Ten WHO-Defined Complications

1. Impaired Consciousness (Cerebral Malaria)

  • Glasgow Coma Scale score <11
  • Unarousable coma (inability to localize pain)
  • Represents the most severe neurological manifestation with 15-25% mortality 2
  • Must exclude other causes of encephalopathy before diagnosis

2. Multiple Convulsions

  • Defined as >2 seizures within 24 hours
  • More common in younger patients (mean age 5.9 years) 3
  • Associated with higher parasite counts (mean 69,972 parasites/μL) 3

3. Prostration

  • Patient unable to sit, stand, or walk without assistance
  • Represents severe systemic compromise
  • Common presenting feature in endemic settings 1

4. Acute Respiratory Distress Syndrome (ARDS) / Pulmonary Edema

  • Radiologically confirmed pulmonary edema
  • PaO₂ <60 mm Hg and/or SpO₂ <92% in ambient air
  • Carries high mortality risk (9 of 12 deaths in one series due to MODS/ARDS) 4
  • Pulmonary edema is rare (<0.5%) with appropriate fluid management 5

5. Acute Renal Failure

  • Serum creatinine >3 mg/dL (>265 μmol/L)
  • Oliguria or anuria (urine output <400 mL/24 hours)
  • Strong predictor of mortality (p<0.001) 6
  • High parasite index and abnormal renal function predict complications 4

6. Severe Anemia

  • Hemoglobin <7 g/dL or hematocrit <20% with parasite count >10,000/μL
  • Most common complication in some settings (45.4% of severe cases) 3
  • More frequent in younger children (mean age 5.6 years) 3

7. Hypoglycemia

  • Blood glucose <40 mg/dL (<2.2 mmol/L)
  • May precipitate seizures or posturing 5
  • Higher blood glucose paradoxically associated with cerebral malaria and mortality 3

8. Acidosis / Hyperlactatemia

  • pH <7.35 or plasma bicarbonate <15 mmol/L
  • Venous plasma lactate >5 mmol/L
  • Often accompanied by compensated shock features 5
  • Base deficit >8 mmol/L indicates metabolic acidosis 5

9. Shock (Circulatory Collapse)

  • Systolic blood pressure <80 mm Hg (<70 mm Hg if <1 year)
  • Associated with tachycardia, cold peripheries, prolonged capillary refill time (≥2 seconds)
  • Strong predictor of complications (p<0.001) 6
  • Hypotension is a late feature complicating 25% of severe acidosis cases 5

10. Bleeding / Disseminated Intravascular Coagulation

  • Recurrent or prolonged bleeding from nose, gums, or venipuncture sites
  • Hematemesis or melena
  • Laboratory evidence of DIC 7
  • Observed in approximately one-third of severe cases 7

Additional Important Criteria

Jaundice

  • Plasma or serum bilirubin >3 mg/dL (>50 μmol/L) combined with parasite count >100,000/μL
  • For P. knowlesi: parasite density >20,000/μL 1
  • Hepatic involvement strongly predicts complications (p<0.002) 6

Hyperparasitemia

  • Critical threshold varies by immunity status:
    • 5% for non-immune subjects

    • 10% for semi-immune subjects 1

  • European/North American guidelines use lower thresholds:
    • 2% for patients from non-endemic regions 1

    • Most controversial criterion with thresholds ranging 2-5% across guidelines 1
  • For P. knowlesi: >100,000/μL indicates severe disease 1

Critical Clinical Pitfalls

Thrombocytopenia is NOT a WHO criterion for severe malaria despite being extremely common (86% of cases) 4, 8. The most common reason for inappropriate artesunate overuse is misclassifying thrombocytopenia as severe malaria 8.

Multiple organ dysfunction (MOD) was present in 70% of severe cases in one series and represents a significant predictor of poor outcomes 6, though it's not explicitly listed as a single WHO criterion but rather represents the combination of multiple complications.

Any single criterion is sufficient for diagnosing severe malaria and mandates intravenous artesunate treatment 1. The presence of end-organ damage at any parasitemia level indicates severe disease requiring parenteral therapy 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.